Le Lézard3d
Ansys and NVIDIA to Demonstrate New Era of In-Silico Cardiovascular Research at GTC
Ansys  and NVIDIA today unveiled a new technology framework enabling customers to design tailored solutions using the power of AI, advanced simulation, and physically-based visualization. Converging ...
United Therapeutics price target lowered to $314 from $328 at BofA
BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm ...
Engineering News-Record9d
Best Manufacturing: United Therapeutics cGMP Warehouse
Building a climate-controlled warehouse and logistics facility for United Therapeutics in North Carolina’s Research Triangle was a matter of power management and careful planning. The facility ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Molecular Partners (MOLN), United Therapeutics (UTHR) and Universal Health (UHS)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molecular Partners (MOLN – Research Report), ...
Yahoo Finance24d
United Therapeutics (NASDAQ:UTHR) Reports Q4 In Line With Expectations
Biotechnology company United Therapeutics (NASDAQ:UTHR) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.7% year on year to $735.9 million. Its GAAP profit of $6.19 per ...
Yahoo Finance25d
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings
Biotechnology company United Therapeutics (NASDAQ:UTHR) will be reporting earnings tomorrow before market open. Here’s what investors should know. United Therapeutics beat analysts’ revenue ...
ETF Daily News20d
United Therapeutics’ (UTHR) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $ ...
Seeking Alpha25d
United Therapeutics: A Unique Business With High Margins And Expansion Potential
United Therapeutics is highly undervalued with a P/E of 16x and EV/EBITDA of 8.64x, compared to sector medians of 28x and 15.15x, respectively. The company shows strong revenue growth, driven by ...
SFGate24d
United Therapeutics: Q4 Earnings Snapshot
SILVER SPRING, Md. (AP) — SILVER SPRING, Md. (AP) — United Therapeutics Corp. (UTHR) on Wednesday reported fourth-quarter net income of $301.3 million. The Silver Spring, Maryland-based ...
ETF Daily News7d
Proficio Capital Partners LLC Purchases New Shares in United Therapeutics Co. (NASDAQ:UTHR)
United Therapeutics Co. has a fifty-two week low of $221.53 and a fifty-two week high of $417.82. The company has a market cap of $13.80 billion, a PE ratio of 13.49, a price-to-earnings-growth ...
Yahoo Finance24d
Why United Therapeutics (UTHR) Stock Is Down Today
Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) fell 10.9% in the afternoon session after the company reported disappointing fourth-quarter results: EPS missed analysts' expectations ...